Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurent Servais

Showing results (1-10 of 246) with videos related to

Pageof 25
Sort By:
Mental Retardation and Developmental Disabilities Research Reviews|January 26, 2006
Sexual health care in persons with intellectual disabilitiesLaurent Servais
The Lancet. Neurology|September 22, 2023
Tamoxifen in children with Duchenne muscular dystrophyLaurent Servais
Developmental Medicine and Child Neurology|April 10, 2019
Video games to measure outcome for children with neuromuscular disordersLaurent Servais
The Lancet. Neurology|December 13, 2025
2025 for neuromuscular diseases: a year of multiple advancesLaurent Servais
Journal of Neuromuscular Diseases|September 3, 2019
"The Times They Are a-Changin'." In reply to El-Zaidy et al.: AVXS-101 (Onasemnogene Abeparvovec) for SMA1: Comparative Study with a Prospective Natural History CohortLaurent Servais
The Lancet Regional Health. Europe|November 6, 2024
Gene therapy for spinal muscular atrophy: timing is keyLaurent Servais
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 19, 2025
Prenatal treatment of spinal muscular atrophyLaurent Servais
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|January 11, 2023
Good News Never HurtsSithara Ramdas, Laurent Servais
Therapeutics and Clinical Risk Management|October 22, 2019
Clinical Evidence Supporting Early Treatment Of Patients With Spinal Muscular Atrophy: Current PerspectivesTamara Dangouloff, Laurent Servais
Expert Opinion on Pharmacotherapy|January 25, 2020
New treatments in spinal muscular atrophy: an overview of currently available dataSithara Ramdas, Laurent Servais
Pageof 25

Showing results (1-10 of 246) with videos related to

Sort By:
Pageof 25
Mental Retardation and Developmental Disabilities Research Reviews|January 26, 2006
Sexual health care in persons with intellectual disabilitiesLaurent Servais
The Lancet. Neurology|September 22, 2023
Tamoxifen in children with Duchenne muscular dystrophyLaurent Servais
Developmental Medicine and Child Neurology|April 10, 2019
Video games to measure outcome for children with neuromuscular disordersLaurent Servais
The Lancet. Neurology|December 13, 2025
2025 for neuromuscular diseases: a year of multiple advancesLaurent Servais
Journal of Neuromuscular Diseases|September 3, 2019
"The Times They Are a-Changin'." In reply to El-Zaidy et al.: AVXS-101 (Onasemnogene Abeparvovec) for SMA1: Comparative Study with a Prospective Natural History CohortLaurent Servais
The Lancet Regional Health. Europe|November 6, 2024
Gene therapy for spinal muscular atrophy: timing is keyLaurent Servais
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 19, 2025
Prenatal treatment of spinal muscular atrophyLaurent Servais
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|January 11, 2023
Good News Never HurtsSithara Ramdas, Laurent Servais
Therapeutics and Clinical Risk Management|October 22, 2019
Clinical Evidence Supporting Early Treatment Of Patients With Spinal Muscular Atrophy: Current PerspectivesTamara Dangouloff, Laurent Servais
Expert Opinion on Pharmacotherapy|January 25, 2020
New treatments in spinal muscular atrophy: an overview of currently available dataSithara Ramdas, Laurent Servais
Pageof 25